MedTrace Logo

Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer

NCT00005075 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2013-11-06

No results posted yet for this study

Summary

RATIONALE: Ultrasound therapy kills tumor cells by heating them to several degrees above body temperature. This treatment may be effective for prostate cancer.

PURPOSE: Phase III trial to determine the effectiveness of ultrasound therapy in treating patients who have stage I or stage II prostate cancer that has recurred following radiation therapy.

Conditions

Interventions

PROCEDURE

high-intensity focused ultrasound ablation

Sponsors & Collaborators

  • EDAP Technomed

    lead INDUSTRY

Principal Investigators

  • Suzanne Courtney, MD · EDAP Technomed

Study Design

Purpose
TREATMENT

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005075 on ClinicalTrials.gov